Defining Clinical Response Criteria and Early Response Criteria for Precision Oncology: Current State-of-the-Art and Future Perspectives

In this era of precision oncology, there has been an exponential growth in the armamentarium of genomically targeted therapies and immunotherapies. Evaluating early responses to precision therapy is essential for “go” versus “no go” decisions for these molecularly targeted drugs and agents that arm...

Descripción completa

Detalles Bibliográficos
Autores principales: Subbiah, Vivek, Chuang, Hubert H., Gambhire, Dhiraj, Kairemo, Kalevi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Concept Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373019/
https://www.ncbi.nlm.nih.gov/pubmed/28212290
http://dx.doi.org/10.3390/diagnostics7010010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373019/
https://www.ncbi.nlm.nih.gov/pubmed/28212290
http://dx.doi.org/10.3390/diagnostics7010010

Ejemplares similares